The Dietary Approaches to Stop Hypertension (DASH) Eating Pattern in Special Populations

被引:0
作者
Crystal C. Tyson
Chinazo Nwankwo
Pao-Hwa Lin
Laura P. Svetkey
机构
[1] Duke University Medical Center,Division of Nephrology, Department of Medicine
[2] Duke University Medical Center,Sarah W. Stedman Nutrition and Metabolism Center
[3] Duke University Medical Center,Duke Hypertension Center
来源
Current Hypertension Reports | 2012年 / 14卷
关键词
Hypertension; Prehypertention; Stage I hypertension; Blood pressure; BP; Diet; Nutrition therapy; Lifestyle interventions; Medication therapy; Combination therapy; Chronic kidney disease; CKD; Diabetes mellitus; DM; Cardiovascular disease; CVD; Renin-angiotensin-aldosterone system inhibitors; RAAS inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
The Dietary Approaches to Stop Hypertension (DASH) trial showed that a diet rich in fruits, vegetables, low-fat dairy products with reduced total and saturated fat, cholesterol, and sugar-sweetened products effectively lowers blood pressure in individuals with prehypertension and stage I hypertension. Limited evidence is available on the safety and efficacy of the DASH eating pattern in special patient populations that were excluded from the trial. Caution should be exercised before initiating the DASH diet in patients with chronic kidney disease, chronic liver disease, and those who are prescribed renin-angiotensin-aldosterone system antagonist, but these conditions are not strict contraindications to DASH. Modifications to the DASH diet may be necessary to facilitate its use in patients with chronic heart failure, uncontrolled diabetes mellitus type II, lactose intolerance, and celiac disease. In general, the DASH diet can be adopted by most patient populations and initiated simultaneously with medication therapy and other lifestyle interventions.
引用
收藏
页码:388 / 396
页数:8
相关论文
共 269 条
[1]  
Yoon SS(2010)Recent trends in the prevalence of high blood pressure and its treatment and control, 1999–2008 NCHS Data Brief 48 1-8
[2]  
Ostchega Y(1993)Blood pressure, systolic and diastolic, and cardiovascular risks. US population data Arch Intern Med 153 598-615
[3]  
Louis T(2000)Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration Lancet 356 1955-64
[4]  
Stamler J(1997)A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group N Engl J Med 336 1117-24
[5]  
Stamler R(2003)The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560-72
[6]  
Neaton JD(2004)Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV J Hum Hypertens 18 139-85
[7]  
Neal B(2010)2010 Canadian hypertension education program recommendations. An annual update Can Fam Physician 56 649-53
[8]  
MacMahon S(1974)Blood pressure in vegetarians Am J Epidemiol 100 390-8
[9]  
Chapman N(1979)Dietary fibre and blood pressure Br Med J 2 1541-3
[10]  
Appel LJ(1996)Dietary protein and blood pressure JAMA 275 1598-603